{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T04:09:59Z","timestamp":1746677399401,"version":"3.40.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Male breast cancer is a rare disease that accounts for less than 1% of all cancers in men and less than 1% of all diagnosed breast cancers. We retrospectively evaluated clinicopathologic features, treatment options, and overall survival in male breast cancer cases over 10 years (2012\u20132021).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this descriptive-cross-sectional study, the men with a breast cancer patient information based on demographic characteristics, type of surgery performed, pathological characteristics of samples (including the type of tumor involving lymph nodes and its grade), distant metastasis, immunohistochemical markers as well as family history of cancer, number of chemotherapy and radiotherapy sessions, use of anabolic drugs, and patient survival after surgery were recorded in the designed checklist.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The results showed that the mean age of men with breast cancer was 56.14\u2009\u00b1\u200914.59. Invasive ductal carcinoma was diagnosed in 86.3% of patients. In addition, metastasis occurred in 23.5% of patients, and most metastases occurred in the liver and then in the bone marrow, respectively. The highest frequency was related to stage IIB, with a frequency of 29.4%. The overall survival rate of 1, 3, and 5 years for 51 cases was 96%, 91%, and 65%, respectively, with an average survival period of 96 months. There was a significant relationship between age, metastasis, and disease stage with the survival status of patients (<jats:italic>P<\/jats:italic>\u2009=\u20090.03).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In the present study, old age, higher stage, and metastasis in male breast cancer were associated with unfavorable survival.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s43046-025-00294-y","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T13:08:13Z","timestamp":1746623293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Male breast cancer: common biomarkers, clinicopathology, and outcomes in the west of Iran"],"prefix":"10.1186","volume":"37","author":[{"given":"Ali","family":"Azizi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrin","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bayan","family":"Faridi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazaher","family":"Ramezani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"294_CR1","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1245\/s10434-010-1468-3","volume":"18","author":"JLDA Gnerlich","year":"2011","unstructured":"Gnerlich JL DA, Jeffe DB, Seelam S, Kimbuende E, Margenthaler JA. Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration. Annals of surgical oncology. 2011;18:1837-44.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"294_CR2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.annepidem.2005.01.001","volume":"15","author":"TDKH Hill","year":"2005","unstructured":"Hill TDKH, Tyczynski JE. Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival. Annals of epidemiology. 2005;15(10):773\u201380.","journal-title":"Annals of epidemiology"},{"issue":"33","key":"294_CR3","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1200\/JCO.2011.36.8902","volume":"29","author":"HVH Miao","year":"2011","unstructured":"Miao HVH, Chia K-S, Bouchardy Magnin C, Pukkala E, Lar\u00f8nningen S, et al. Incidence and outcome of male breast cancer: an international population-based study. Journal of Clinical Oncology. 2011;29(33):4381\u20136.","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"294_CR4","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S0039-6060(99)70135-2","volume":"126","author":"CJP Scott-Conner","year":"1999","unstructured":"Scott-Conner C JP, Menck H, Winchester D. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery 1999;126(4):775-81.","journal-title":"Surgery"},{"issue":"2","key":"294_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1349-7006.2008.01032.x","volume":"100","author":"LHP Thalib","year":"2009","unstructured":"LHP Thalib. Survival of male breast cancer patients: population-based cohort study Cancer Sci. 2009;100(2):292-5.","journal-title":"Cancer Sci"},{"issue":"4","key":"294_CR6","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3892\/ol.2012.809","volume":"4","author":"LTL Baojiang","year":"2012","unstructured":"Baojiang L TL, Gang L, Li Z. Male breast cancer: A retrospective study comparing survival with female breast cancer. Oncology letters. 2012;4(4):642-6.","journal-title":"Oncol Lett"},{"issue":"10","key":"294_CR7","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/jjco\/hyt116","volume":"43","author":"XLX Chen","year":"2013","unstructured":"Chen X LX, Zhang L, Li S, Shi Y, Tong Z. Poorer survival of male breast cancer compared with female breast cancer patients may be due to biological differences. Japanese journal of clinical oncology. 2013;43(10):954-63.","journal-title":"Jpn J Clin Oncol"},{"issue":"10","key":"294_CR8","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/archsurg.139.10.1079","volume":"139","author":"MBKI El-Tamer","year":"2004","unstructured":"El-Tamer MB KI, Troxel A, Li H, Joseph K-A, Ditkoff B-A, et al. Men with breast cancer have better disease-specific survival than women. Archives of Surgery. 2004;139(10):1079-82.","journal-title":"Arch Surg"},{"issue":"5","key":"294_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.clbc.2014.02.008","volume":"14","author":"MBV Iorfida","year":"2014","unstructured":"Iorfida MBV, Rotmensz N, Munzone E, Bonanni B, Viale G, et al. Outcome of male breast cancer: a matched single-institution series. Clinical breast cancer. 2014;14(5):371\u20137.","journal-title":"Clinical breast cancer"},{"key":"294_CR10","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1245\/s10434-013-3377-8","volume":"21","author":"ACW Kwong","year":"2014","unstructured":"Kwong A CW, Mang OW, Wong CH, Suen DT, Leung R, et al. Male breast cancer: a population-based comparison with female breast cancer in Hong Kong, Southern China: 1997\u20132006. Annals of surgical oncology. 2014;21:1246-53.","journal-title":"Ann Surg Oncol"},{"key":"294_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s10147-013-0555-4","volume":"19","author":"DXG Liu","year":"2014","unstructured":"Liu D XG, Chen M. Clinicopathologic characteristics and survival of male breast cancer. International journal of clinical oncology. 2014;19:280-7.","journal-title":"Int J Clin Oncol"},{"key":"294_CR12","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1245\/s10434-009-0327-6","volume":"16","author":"FSM Marchal","year":"2009","unstructured":"Marchal F SM, Marchal C, Lesur A, Desandes E. Men with breast cancer have same disease-specific and event-free survival as women. Annals of surgical oncology. 2009;16:972-8.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"294_CR13","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1007\/s00066-012-0118-z","volume":"188","author":"AGC M\u00fcller","year":"2012","unstructured":"M\u00fcller A GC, Rehm H, Eckert F, Bamberg M, Hehr T, et al. Are there biologic differences between male and female breast cancer explaining inferior outcome of men despite equal stage and treatment?! . Strahlentherapie und Onkologie. 2012;188(9):782.","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"294_CR14","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10549-022-06689-y","volume":"196","author":"LLG Nicosia","year":"2022","unstructured":"Nicosia L LG, Sargenti M, Bozzini AC, Farante G, Vila J, et al. Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center. Breast Cancer Research and Treatment. 2022;196(2):371-7.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"294_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/annonc\/mdx651","volume":"29","author":"FBJ Cardoso","year":"2018","unstructured":"Cardoso F BJ, Slaets L, Van Deurzen C, van Leeuwen-Stok E, Porter P, et al. Characterization of male breast cancer: results of the EORTC 10085\/TBCRC\/BIG\/NABCG International Male Breast Cancer Program. . Annals of Oncology. 2018;29(2):405-17.","journal-title":"Ann Oncol"},{"key":"294_CR16","first-page":"724","volume":"27","author":"LFF Mangone","year":"2020","unstructured":"Mangone L FF, Mancuso P, Carrozzi G, Michiara M, Falcini F, et al. Epidemiology and biological characteristics of male breast cancer in Italy. Breast Cancer Research and Treatment. 2020;27:724-31.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"294_CR17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/ijc.32106","volume":"145","author":"PZV Rizzolo","year":"2019","unstructured":"Rizzolo P ZV, Silvestri V, Valentini V, Zanna I, Bianchi S, et al. Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy. International journal of cancer. 2019;145(2):390-400.","journal-title":"Int J Cancer"},{"key":"294_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10555-018-9761-x","volume":"37","author":"RAGK Leon-Ferre","year":"2018","unstructured":"Leon-Ferre RA GK, Hieken TJ, Mutter RW, Couch FJ, Jimenez RE, et al. A contemporary review of male breast cancer: current evidence and unanswered questions. . Cancer and Metastasis Reviews. 2018;37:99-614.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"294_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/srep45293","volume":"7","author":"MPSRS Humphries","year":"2017","unstructured":"Humphries MP SRS, Honarpisheh H, Cserni G, Dent J, Fulford L, et al. Characterisation of male breast cancer: a descriptive biomarker study from a large patient series. Scientific reports. 2017;7(1):452- 93.","journal-title":"Sci Rep"},{"issue":"1","key":"294_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/ijc.30722","volume":"141","author":"DGLE Romaguera","year":"2017","unstructured":"Romaguera D GLE, Molinuevo A, de Batlle J, Mendez M, Moreno V, et al. Adherence to nutrition\u2010based cancer prevention guidelines and breast, prostate and colorectal cancer risk in the MCC\u2010S pain case\u2013control study. International journal of cancer 2017;141(1):83-93.","journal-title":"Int J Cancer"},{"issue":"2","key":"294_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/cncr.30337","volume":"123","author":"VZV Silvestri","year":"2017","unstructured":"Silvestri VZV, Valentini V, Rizzolo P, Navazio AS, Coppa A, et al. Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene. Cancer. 2017;123(2):210\u20138.","journal-title":"Cancer"},{"issue":"11","key":"294_CR22","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jamaoncol.2019.2803","volume":"5","author":"FSX Wang","year":"2019","unstructured":"Wang FSX, Meszoely I, Pal T, Mayer IA, Yu Z, et al. Overall mortality after diagnosis of breast cancer in men vs women. JAMA oncology. 2019;5(11):1589\u201396.","journal-title":"JAMA oncology"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-025-00294-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-025-00294-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-025-00294-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T13:08:13Z","timestamp":1746623293000},"score":1,"resource":{"primary":{"URL":"https:\/\/jenci.springeropen.com\/articles\/10.1186\/s43046-025-00294-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["294"],"URL":"https:\/\/doi.org\/10.1186\/s43046-025-00294-y","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research received approval from the Research Ethics Committee of the School of Medicine at Kermanshah University of Medical Sciences (Approval ID: IR.KUMS.MD.REC.1400.074).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The present investigation did not involve any human interaction.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}